0000711377-17-000010.txt : 20170523 0000711377-17-000010.hdr.sgml : 20170523 20170523153521 ACCESSION NUMBER: 0000711377-17-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170519 FILED AS OF DATE: 20170523 DATE AS OF CHANGE: 20170523 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGEN CORP CENTRAL INDEX KEY: 0000711377 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 382367843 STATE OF INCORPORATION: MI FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 620 LESHER PLACE CITY: LANSING STATE: MI ZIP: 48912 BUSINESS PHONE: 5173729200 MAIL ADDRESS: STREET 1: 620 LESHER PLACE CITY: LANSING STATE: MI ZIP: 48912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRADLEY EDWARD CENTRAL INDEX KEY: 0001189021 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17988 FILM NUMBER: 17863651 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-05-19 0 0000711377 NEOGEN CORP NEOG 0001189021 BRADLEY EDWARD 0 1 0 0 vice President Common Stock 2017-05-19 4 S 0 5000 61.3317 D 96512 D These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 5, 2017 Steven J Quinlan (Attorney in Fact) 2017-05-23